| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2000;69:1414-1419
© 2000 The Society of Thoracic Surgeons
a Department of Cardiac Surgery, University Hospital Ulm, Ulm, Germany
Address reprint requests to Dr Pecher, Department of Cardiac Surgery, University Hospital Ulm, Steinhövelstr 9, D-89081 Ulm, Germany;
e-mail: peter.pecher{at}medizin.uni-ulm.de
Background. Using the human fibroblast growth factor we could already demonstrate the induction of neoangiogenesis in the ischemic human myocardium.
Methods. Forty patients, who were undergoing elective coronary artery bypass grafting were randomly selected and allotted either to a treatment or a control group. In 20 patients (study group) fibroblast growth factor was injected directly into the myocardium, close to the left anterior descending coronary artery. The control group comprised 20 patients who had been injected with heat denatured fibroblast growth factor. The 3-year follow-up consisted of a clinical examination, echocardiography, and selective imaging of the internal mammary artery bypass using angiography.
Results. As with the early results, a dense new capillary network could be demonstrated angiographically in the region where the factor had been injected. Echocardiography showed an increase in the left ventricular ejection fraction in the study group. We also found a more pronounced improvement in the clinical appearance of the patients with fibroblast growth factor.
Conclusions. Fibroblast growth factor, in addition to operative myocardial revascularization, may be the appropriate treatment for patients with peripheral stenosis or diffuse coronary arteriosclerosis. It is necessary to confirm these results in further studies on a larger group of patients.
This article has been cited by other articles:
|
|
 |
|
  F. W. Sellke, R. Laham, E. J. Suuronen, and M. Ruel Angiogenesis for the treatment of inoperable coronary disease: the future. Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2006; 10(2): 184 - 188. [Abstract] [PDF]
|
|
|
|
 |
|
 C. J Teng, K. Lachapelle, and R. C. Chiu Reappraisal of Recent Clinical Trials of Angiogenic Therapy in Myocardial Ischemia Asian Cardiovasc Thorac Ann, March 1, 2005; 13(1): 90 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.H. Tayebjee, G.Y.H. Lip, and R.J. MacFadyen Collateralization and the response to obstruction of epicardial coronary arteries QJM, May 1, 2004; 97(5): 259 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-S. Jiang, W. Srisakuldee, F. Soulet, G. Bouche, and E. Kardami Non-angiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion Cardiovasc Res, April 1, 2004; 62(1): 154 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. W. Sellke and M. Ruel Vascular growth factors and angiogenesis in cardiac surgery Ann. Thorac. Surg., February 1, 2003; 75(2): S685 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ruel, R. A. Kelly, and F. W. Sellke Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy Card. Surg. Adult, January 1, 2003; 2(2003): 715 - 750. [Full Text]
|
|
|
|
 |
|
 C. Heilmann, P. von Samson, K. Schlegel, T. Attmann, B.-U. von Specht, F. Beyersdorf, and G. Lutter Comparison of protein with DNA therapy for chronic myocardial ischemia using fibroblast growth factor-2 Eur. J. Cardiothorac. Surg., December 1, 2002; 22(6): 957 - 964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Robicsek and A. A. Fokin Vineberg operation combined with growth factor implantation Ann. Thorac. Surg., September 1, 2002; 74(3): 974 - 975. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ruel, R. J. Laham, J. A. Parker, M. J. Post, J. A. Ware, M. Simons, and F. W. Sellke Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 28 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Lindner and T. Maciag The Putative Convergent and Divergent Natures of Angiogenesis and Arteriogenesis Circ. Res., October 26, 2001; 89(9): 747 - 749. [Full Text] [PDF]
|
|
|
|
|
|
W. D. Johnson, V. S. Chekanov, V. V. Nikolaychik, and N. Kipshidze Vineberg procedure combined with therapeutic angiogenesis: old wine in a new bottle Ann. Thorac. Surg., October 1, 2001; 72(4): 1443 - 1444. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Azrin Angiogenesis, protein and gene delivery Br. Med. Bull., October 1, 2001; 59(1): 211 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Oesterle, N. Reifart, E. Hauptmann, M. Hayase, and A. C. Yeung Percutaneous In Situ Coronary Venous Arterialization : Report of the First Human Catheter-Based Coronary Artery Bypass Circulation, May 29, 2001; 103(21): 2539 - 2543. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
